| mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
9e-06 |
| mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
| mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.2 |
7e-05 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-05 |